openPR Logo
Press release

Prosthetic Heart Valves Market growing at a CAGR of 12.9% during 2016 to 2021

10-10-2017 01:12 PM CET | Health & Medicine

Press release from: Market Data Forecast

Prosthetic Heart Valves Market growing at a CAGR of 12.9% during

The Global Prosthetic Heart Valves Market was worth USD 4.28 billion in 2016 and estimated to be growing at a CAGR of 12.9%, to reach USD 7.85 billion by 2021. The heart plays a vital role in the proper functioning of the human body by controlling the blood flow. There are mainly four main types of valves in the heart, namely tricuspid, pulmonary, mitral and aortic valves. A prosthetic heart valve is a device that is implanted in a patient suffering from valve failures in the heart or other heart diseases which puts the patient at risk of heart failure. They are implanted both as a pre-emptive treatment and a reactive treatment.

Browse 180 Pages of recent research on Global Prosthetic Heart Valves Market @ http://www.marketdataforecast.com/market-reports/global-prosthetic-heart-valves-market-2602/

The valves in the heart are integral to the normal functioning of the human body. They are evolved to perform tasks such as controlling the unidirectional flow of blood through the valve structure. Artificial valves must be designed to perform these tasks in addition to being accepted by the body after transplantation. Tissue valves are normally preferred over mechanical valves because of the latter requiring additional anticoagulant administration for the proper functioning of the valve. The requirement is lifelong whereas the tissue valve has no such additional treatment required.

The rise of the Prosthetic Heart Valves market is mainly driven by factors such as rising geriatric population, rise in the prevalence of cardiac disorders such as rheumatic heart diseases and the change in lifestyle of the people. Other major contributors include the technological advancements, the increase in patient awareness, demand for minimally invasive cardiovascular surgeries and rise in the number of medical centers that have the provision to perform a heart surgery. Inspite of the advantages being numerous, the prosthetic heart valve market remains in check by restraints such as the excessive costs of the valve as well as the treatment itself and the very strict approval process for prosthetic valves before they are introduced into the market.

Avail Sample Market Brochure of the report @ http://www.marketdataforecast.com/market-reports/global-prosthetic-heart-valves-market-2602/request-sample

Prosthetic Heart Valves Market Segmentation:
By Type:
• Mechanical Heart Valve
• Tissue Heart Valve
• Transcatheter Heart Valve
• Y-o-Y Growth Analysis, By Type

By Geography:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Key Players of the Market:
• Corvia Medical
• CardioKinetix
• Biomerics LLC
• Lepu Medical Technology
• XELTIS BV
• Comed BV
• Meril Life Sciences
• SYSMETIS SA
• HLT
• Transcatheter Technologies GmbH

The Global Prosthetic Heart Valves market is broadly classified based on type into Mechanical Heart Valve, Tissue Heart Valve and Transcatheter Heart Valve. Based on geography, the global market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. The Prosthetic Heart Valves Market is dominated by North America in 2016 with the region accounting for over a third of the overall market share. North America was followed next in line by Europe and Asia-Pacific. Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region. Another market that shows promise in the coming years is Latin America.

Make an Inquiry before Buying @ http://www.marketdataforecast.com/market-reports/global-prosthetic-heart-valves-market-2602/inquire

About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Media Contact:
Abhishek Shukla
International Business Development Manager
Market Data Forecast
Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prosthetic Heart Valves Market growing at a CAGR of 12.9% during 2016 to 2021 here

News-ID: 764986 • Views:

More Releases from Market Data Forecast

Personalized Nutrition Market is growing at a brisk pace
Personalized Nutrition Market is growing at a brisk pace
The global personalized nutrition market size is expected to be valued at USD 10.84 thousand units in 2024 and reach USD 21.80 thousand units by 2029, growing at a CAGR of 15.0% from 2024 to 2029. Global Personalized Nutrition Market Report Scope: • Market Size (2029): USD 21.80 thousand units • Market Size (2024): USD 10.84 thousand units • CAGR (2024 to 2029): 15% • Base Year: 2023 • Forecast Period: 2024 to 2029 • Segments
Anticipating the Future of the Antibodies Market
Anticipating the Future of the Antibodies Market
The Antibodies market size is expected to be valued at USD 183.7 billion in 2024 and reach USD 183.7 billion by 2029, growing at a CAGR of 11.31% from 2024 to 2029. Antibodies, also known as immunoglobulins, are Y-shaped proteins the immune system produces in response to foreign substances called antigens. Antibodies are employed in various applications, such as diagnostics, research, and therapeutics, which play a crucial role. Global Antibodies Market Report
The Power of Herbal Medicine in Healthcare Market
The Power of Herbal Medicine in Healthcare Market
The herbal medicine market size is expected to be valued at USD 215.4 billion in 2024 and reach USD USD 305.3 billion by 2029, growing at a CAGR of 7.22% from 2024 to 2029. Herbal medicines, derived from plants or plant parts like leaves, flowers, seeds, roots, and stems, have been utilized across diverse cultures for centuries due to their therapeutic properties. They can be prepared in various forms, such as
Innovative Surge Wearable Medical Devices Market Thrives
Innovative Surge Wearable Medical Devices Market Thrives
The global wearable medical devices market size is expected to be valued at USD 11194 million in 2024 and reach USD 28322 million by 2029, growing at a CAGR of 20.40 % from 2024 to 2029. Wearable medical devices are devices that customers can wear, such as activity trackers and smartwatches. These devices are designed to monitor and collect real-time data on customer health and fitness. Global Wearable Medical Devices Market

All 5 Releases


More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an